Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thrice Weekly DOTS in TB Patients With and Without HIV
NCT00698334Phase 3Completed
- Sponsor
- AIIMS New Delhi
- Start
- Apr 2006
- Primary completion
- Sep 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of isoniazid, rifampicin, ethambutol, pyrazinamide in Tuberculosis (TB), sponsored by AIIMS New Delhi. Started Apr 2006; status: completed.
02
Drugs
isoniazidrifampicinethambutolpyrazinamide
03
Conditions
Tuberculosis (TB)
Beyond the preview
Go deeper on NCT00698334.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00698334.